Cargando…
Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study
BACKGROUND/AIMS: Although anti-tumor necrosis factor (TNF) agents have been widely used to treat ulcerative colitis (UC), the real-world incidence of suboptimal response to anti-TNF agents has not been thoroughly investigated, especially among Asians. METHODS: Using the Korean National Health Insura...
Autores principales: | Shin, Ju-Young, Park, Hye-Min, Lee, Min-Young, Jeon, Ja-Young, Yoo, Hyun-Jeong, Ye, Byong Duk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593500/ https://www.ncbi.nlm.nih.gov/pubmed/33785664 http://dx.doi.org/10.5009/gnl20353 |
Ejemplares similares
-
The real-world outcomes of vedolizumab in patients with ulcerative
colitis in Korea: a multicenter retrospective study
por: Ye, Byong Duk, et al.
Publicado: (2021) -
Lesson from Real-World Experience: Optimal Treatment with Anti-Tumor Necrosis Factor for Ulcerative Colitis
por: Chun, Jaeyoung
Publicado: (2021) -
Ustekinumab in ulcerative colitis‐ insights from the real‐world data
por: Veisman, Ido, et al.
Publicado: (2022) -
Increased Cumulative Incidence of Dermatomyositis in Ulcerative Colitis: a Nationwide Cohort Study
por: Tseng, Chia-Chun, et al.
Publicado: (2016) -
Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
por: Oh, Shin Ju, et al.
Publicado: (2021)